Bilateral internal thoracic artery grafting in isolated coronary artery bypass grafting: A 35-year experience

Youssef Shahin1,2,3, Tedy Sawma1, Yazan AlJamal1

  • 1Mayo Clinic, Cardiovascular Surgery, Rochester, Minn.

JTCVS Open
|December 31, 2025
PubMed

Insights

Bilateral internal thoracic artery grafting offers superior long-term survival in coronary artery bypass grafting, yet its use has declined recently. Despite longer operative times, it shows comparable wound complication rates and should be more widely adopted.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Vascular Surgery

Background:

  • The use of bilateral internal thoracic artery (BITA) grafting in coronary artery bypass grafting (CABG) has evolved over decades.
  • Understanding trends and outcomes associated with BITA versus non-BITA strategies is crucial for optimizing CABG procedures.

Purpose of the Study:

  • To analyze trends in BITA grafting during isolated CABG over a 35-year period.
  • To compare the outcomes of BITA grafting with non-BITA strategies in a large patient cohort.

Main Methods:

  • A retrospective analysis of 15,991 patients undergoing isolated multivessel CABG from 1990 to 2024.
  • Assessment of grafting trends using chi-square tests and propensity score matching for outcome comparisons.
  • Analysis of patient factors like obesity and diabetes prevalence.

Main Results:

  • BITA grafting use increased initially but declined from 2020-2024, unrelated to patient risk factors.
  • BITA grafting was associated with longer operative times but similar cardiopulmonary bypass and crossclamp durations.
  • Kaplan-Meier analysis demonstrated superior 30-year survival for BITA grafting, with no increase in wound-healing complications.

Conclusions:

  • BITA grafting is underutilized despite proven survival benefits and acceptable complication rates.
  • The recent decline in BITA use is not explained by patient comorbidities, suggesting a need for increased adoption.
  • Further research, including randomized trials, is warranted to optimize CABG strategies utilizing BITA grafts.
Abstract

Related Concept Videos